What is Infliximab?

Category: Prescription Drugs

Most popular types: Remicade Infimab Revellex

false

Infliximab is a monoclonal antibody used in the treatment of a number of autoimmune conditions, including: Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Crohn's disease 160 73
Rheumatoid arthritis 99 50
Ulcerative colitis 42 26
Psoriatic arthritis 40 21
Ankylosing spondylitis 33 16
Psoriasis 13 6

Show all 33 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
30
Moderate
39
Mild
48
None
70

Commonly reported side effects and conditions associated with Infliximab

Side effect Patients
Fatigue 19
Nausea 12
Headaches 10
Joint pain 7
Muscle and joint pain 7
Allergic reaction 4

Show all 107 reported side effects

Dosages

Based on patients currently taking Infliximab

Dosage Patients
100 mg every 8 weeks 5
400 mg every 8 weeks 4
100 mg every 6 weeks 2
100 mg monthly 2
400 mg every 6 weeks 2
700 mg every 6 weeks 2
1 mg every 8 weeks 1
1 other monthly 1
10 mg every 8 weeks 1
10 mg monthly 1

See all 22 dosages

Why patients stopped taking Infliximab

Multiple reasons could be selected

Reason Patients
Did not seem to work 74
Side effects too severe 60
Doctor's advice 41
Other 41
Expense 17
Change in health plan coverage 9
Course of treatment ended 5
Personal research 1
See all 180 patients who've stopped taking Infliximab

Duration

Currently taking Infliximab

Duration Patients
6 months - 1 year 4
1 - 2 years 5
2 - 5 years 8
5 - 10 years 10
10 years or more 10

Stopped taking Infliximab

Duration Patients
Less than 1 month 33
1 - 6 months 32
6 months - 1 year 33
1 - 2 years 30
2 - 5 years 37
5 - 10 years 13
10 years or more 4
Adherence
Adherence Evaluations
Always 163
Usually 10
Sometimes 5
Never taken as prescribed 9
Burden
Burden Evaluations
Very hard to take 14
Somewhat hard to take 65
A little hard to take 56
Not at all hard to take 52
Cost per month
Cost per month Evaluations
$200+ 28
$100-199 10
$50-99 6
$25-49 6
< $25 45
Not specified 92

What people switch to and from

Patients started taking Infliximab after stopping:

Treatment Patients
Adalimumab (Humira) 18
Mesalamine (Pentasa) 12
Etanercept (Enbrel SureClick) 9
Prednisone (Deltasone) 6
Sulfasalazine (Salazopyrin) 6

Show all 25 treatments patients report switching from

Patients stopped taking Infliximab and switched to:

Treatment Patients
Adalimumab (Humira) 23
Abatacept (Orencia) 7
Rituximab (Rituxan) 3
Tocilizumab (Actemra) 3
Azathioprine (Imuran) 2

Show all 19 treatments patients report switching to

Last updated:

9 patient evaluations for Infliximab

Mar 22, 2017 (Started Mar 03, 2017)

  • Effectiveness
    Slight (for psoriatic arthritis)
  • Effectiveness
    Slight (for psoriasis worsened)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 6 mg Every 8 Weeks

  • 0 helpful marks

Jul 21, 2016 (Started Dec 12, 2015)

  • Effectiveness
    Major (for rheumatoid arthritis)
  • Effectiveness
    Moderate (for Crohn's disease)
  • Side effects
    Moderate (rash or skin problems, dry skin, dry throat)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 600 mg Every 8 Weeks
Advice & Tips: It takes commitment and time to work. My infusions are done at the GI clinic while some are outpatient at hospital. They take 3-4 hours and usually am extremely tired and groggy for couple of days.
Cost: $200+ monthly

  • 1 helpful mark

Jun 25, 2013 (Started Jul 01, 2005)

  • Effectiveness
    Major (for Crohn's disease)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 750 mg Every 6 Weeks

  • 0 helpful marks
Last updated:
Showing 3 of 9 patient evaluations for Infliximab